All the latest news and information on the cannabis and psychedelics industries, with updates from the UK and across the globe.
What’s the political landscape for cannabis policy reform in Italy? After an Italian court recently ruled that categorizing hemp flower as a narcotic was ‘absurdly restrictive’, will a new bill…
It looks like Germany could be ready to charge ahead with their plans for recreational cannabis legalisation following ‘very good feedback’ from the EU. But will it be good news…
In recent years, psychedelics have gained much positive traction across the globe. In 2021, the first psychedelic therapy clinic in Britain opened its doors with the aim of treating mental…
What does the future of psychedelic medicine look like in the UK? What treatments might be available? How could they be accessed? Nowadays our news feeds and science journals are…
The UK’s largest medical cannabis company has announced a new capital raise and the completion of an internal restructure. This new raise will support Lyphe Group to become cash flow…
The potential of cannabis medicines to treat symptoms of epilepsy, especially for children who are resistant to other available drugs, has been one of the driving forces behind the liberalisation…
For a country so seemingly liberal, where the national museum includes a ‘rainbow road’ to take you through LGBTQ history, vegan options better than I’ve seen anywhere else in the…
In this episode Paul North, Director of Volteface and guest Alfredo Pascual discuss where Europe is at with regards to recreational cannabis reform and the framing of cannabis policies across…
There’s been a significant amount of overinflation and hype surrounding the CBD industry in the UK. Has the sector begun to stagnate? What should the CBD sector’s next move be?…
We’re all talking about the latest cannabis developments in Germany, but there is one small country right at the corner, which may be even more exciting in terms of cannabis…
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept